Building a Coronavirus Pandemic Response: Sequencing Tools, Therapeutics, and Surveillance

The world watches as the biotechnology community turns every effort toward mitigating the impact of the coronavirus. This panel brings together leading figures to explore how sequencing, synthesis, and gene editing are being put to the ultimate test, and how industry leaders are navigating their companies through these unprecedented times. We’ll explore how synthetic biology is retooling itself for COVID-19 testing and surveillance, identifying promising therapeutic targets, building a back-to-work-and-school testing strategy, and the unique challenges and opportunities for startups.